A CAR-T therapy trial in ten patients has shown “impressive efficacy” in patients with multiple myeloma, according to the study’s doctors. Researchers carried out the study at the Zhejiang University School of Medicine in China. The trial was carried out to judge the safety and efficacy of the experimental treatment in patients with multiple myeloma, including some who had received previous gene therapy treatments for their illnesses. CAR-T stands for “chimeric antigen receptor T-Cell.” The gene-edited CAR-T therapy cells used in the Zhejiang study were developed by Oricell Therapeutics. OriCAR-017 was given to the ten patients in the study, ...Read more
